Optipharm.CO.LTD
Optipharm.CO.,LTD operates as a biomedical solution provider in South Korea. It also engages in animal disease diagnosis, animal medicine, bacteriophage, Medipig, xenogenic organs, VLP vaccines, xenotransplantation, and other optipharm products, as well as veterinary drug for feed additives and laboratory animal Medipig business. The company was formerly known as Optiparm Solution Co., Ltd. and c… Read more
Optipharm.CO.LTD (153710) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.012x
Based on the latest financial reports, Optipharm.CO.LTD (153710) has a cash flow conversion efficiency ratio of 0.012x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩315.25 Million) by net assets (₩25.71 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Optipharm.CO.LTD - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Optipharm.CO.LTD's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Optipharm.CO.LTD Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Optipharm.CO.LTD ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
S.Kijchai Enterprise Public Company Limited
BK:SKN
|
0.023x |
|
Cambuci S.A
SA:CAMB3
|
0.072x |
|
Integra Indocabinet Tbk PT
JK:WOOD
|
0.013x |
|
PDS Biotechnology Corp
NASDAQ:PDSB
|
-0.626x |
|
MicroCloud Hologram Inc.
NASDAQ:HOLO
|
0.004x |
|
PPI Inc
KQ:062970
|
-0.027x |
|
SOTKAMO SILVER AB NAM.
F:VSO
|
N/A |
|
Crest Ventures Limited
NSE:CREST
|
0.015x |
Annual Cash Flow Conversion Efficiency for Optipharm.CO.LTD (2015–2024)
The table below shows the annual cash flow conversion efficiency of Optipharm.CO.LTD from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩27.34 Billion | ₩-595.50 Million | -0.022x | +68.20% |
| 2023-12-31 | ₩25.14 Billion | ₩-1.72 Billion | -0.069x | +18.34% |
| 2022-12-31 | ₩29.01 Billion | ₩-2.43 Billion | -0.084x | -31.87% |
| 2021-12-31 | ₩30.96 Billion | ₩-1.97 Billion | -0.064x | -32.95% |
| 2020-12-31 | ₩33.78 Billion | ₩-1.62 Billion | -0.048x | -480.82% |
| 2019-12-31 | ₩35.61 Billion | ₩447.47 Million | 0.013x | -62.99% |
| 2018-12-31 | ₩35.44 Billion | ₩1.20 Billion | 0.034x | +66.43% |
| 2017-12-31 | ₩12.79 Billion | ₩260.86 Million | 0.020x | -68.03% |
| 2016-12-31 | ₩13.50 Billion | ₩861.36 Million | 0.064x | +136.47% |
| 2015-12-31 | ₩4.30 Billion | ₩-751.51 Million | -0.175x | -- |